Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Boulet

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Experimental Physiology|December 10, 2015
Comparing and characterizing transient and steady-state tests of the peripheral chemoreflex in humansJamie R Pfoh, Michael M Tymko, Maria Abrosimova, et al.
European Journal of Pharmacology|December 1, 2005
A role for cannabinoid receptors, but not endogenous opioids, in the antinociceptive activity of the CB2-selective agonist, GW405833Garth T Whiteside, Susan L Gottshall, Jamie M Boulet, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|April 28, 2022
The coronary vascular response to the metaboreflex at low altitude and during acute and prolonged high altitude in malesAustin J White, Lindsey M Boulet, Brooke M Shafer, et al.
The Journal of Physiology|December 6, 2019
Acute intermittent hypercapnic hypoxia and sympathetic neurovascular transduction in menTroy J R Stuckless, Tyler D Vermeulen, Courtney V Brown, et al.
The Journal of Physiology|April 27, 2019
UBC-Nepal expedition: phenotypical evidence for evolutionary adaptation in the control of cerebral blood flow and oxygen delivery at high altitudeRyan L Hoiland, Connor A Howe, Howard H Carter, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|September 22, 2018
Attenuation of human hypoxic pulmonary vasoconstriction by acetazolamide and methazolamideLindsey M Boulet, Luc J Teppema, Heather K Hackett, et al.
Neuropharmacology|April 9, 2005
Pharmacological and pharmacokinetic characterization of the cannabinoid receptor 2 agonist, GW405833, utilizing rodent models of acute and chronic pain, anxiety, ataxia and catalepsyKenneth J Valenzano, Laykea Tafesse, Gary Lee, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|June 17, 2016
Commentaries on Viewpoint: Why predominantly neurological DCS in breath-hold divers?Glen E Foster, Anthony R Bain, Joshua C Tremblay, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Experimental Physiology|December 10, 2015
Comparing and characterizing transient and steady-state tests of the peripheral chemoreflex in humansJamie R Pfoh, Michael M Tymko, Maria Abrosimova, et al.
European Journal of Pharmacology|December 1, 2005
A role for cannabinoid receptors, but not endogenous opioids, in the antinociceptive activity of the CB2-selective agonist, GW405833Garth T Whiteside, Susan L Gottshall, Jamie M Boulet, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|April 28, 2022
The coronary vascular response to the metaboreflex at low altitude and during acute and prolonged high altitude in malesAustin J White, Lindsey M Boulet, Brooke M Shafer, et al.
The Journal of Physiology|December 6, 2019
Acute intermittent hypercapnic hypoxia and sympathetic neurovascular transduction in menTroy J R Stuckless, Tyler D Vermeulen, Courtney V Brown, et al.
The Journal of Physiology|April 27, 2019
UBC-Nepal expedition: phenotypical evidence for evolutionary adaptation in the control of cerebral blood flow and oxygen delivery at high altitudeRyan L Hoiland, Connor A Howe, Howard H Carter, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|September 22, 2018
Attenuation of human hypoxic pulmonary vasoconstriction by acetazolamide and methazolamideLindsey M Boulet, Luc J Teppema, Heather K Hackett, et al.
Neuropharmacology|April 9, 2005
Pharmacological and pharmacokinetic characterization of the cannabinoid receptor 2 agonist, GW405833, utilizing rodent models of acute and chronic pain, anxiety, ataxia and catalepsyKenneth J Valenzano, Laykea Tafesse, Gary Lee, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|June 17, 2016
Commentaries on Viewpoint: Why predominantly neurological DCS in breath-hold divers?Glen E Foster, Anthony R Bain, Joshua C Tremblay, et al.
Pageof 7